Microspheres in Preventing Lymphatic Fluid Collection After Surgery in Patients With Prostate Cancer

Stopped early · Not applicable

Conditions studied: Lymphocele, Prostate Cancer

In brief

This study is being performed to investigate if the application of Arista absorbable hemostat (AH)®, a product approved to stop surgical bleeding, can prevent lymphoceles. Lymphoceles are collections of lymphatic fluid which can occur after a lymph node dissection for cancer. These fluid collections can become symptomatic in some patients. Arista would be applied to one side of the pelvis after a pelvic lymph node dissection, to see if this decreases the number of postoperative lymph fluid collections seen on a computed tomography (CT) scan after surgery

Key facts

Study ID

NCT01644136

Run by

Ohio State University Comprehensive Cancer Center

People needed

99

Starts

2011-07-14

Expected to finish

2014-05-06

Last updated by the study team

2018-06-28

Who can join

Age: any. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Male patients
• Patients with prostate cancer who are electing to undergo robotic radical prostatectomy with pelvic lymph node dissection at The Arthur G. James Cancer Hospital and Solove Research Institute, The Ohio State University Medical Center by Dr. Ronney Abaza

Where it is running

• The Ohio State University Medical Center — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.